Viriom Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Viriom General Information

Description

Developer of a drug development platform designed to target infectious and malignant diseases. The company's platform offers affordable therapies against life-threatening infections such as human immunodeficiency virus, along with a proprietary pre-clinical lead compound as a potentially curative treatment of chronic Hepatitis B virus, enabling medical practitioners to provide access to new therapies for developed and developing countries.

Contact Information

Website
www.viriom.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1450 Research Boulevard
  • Suite 110
  • Rockville, MD 20850
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 1450 Research Boulevard
  • Suite 110
  • Rockville, MD 20850
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viriom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 02-Sep-2026 Completed Out of Business
6. Secondary Transaction - Private 01-Apr-2025 Completed Pre-Clinical Trials
5. Later Stage VC 06-Dec-2017 Completed Pre-Clinical Trials
4. Grant 11-May-2016 Completed Pre-Clinical Trials
3. Later Stage VC 11-May-2016 Completed Pre-Clinical Trials
2. Early Stage VC 01-Nov-2013 Completed Startup
1. Grant 01-Sep-2010 $5M Completed Startup
To view Viriom’s complete valuation and funding history, request access »

Viriom Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to target infectious and malignant diseases. The company's platform of
Drug Discovery
Rockville, MD
4 As of 2022

Cambridge, MA
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viriom Competitors (51)

One of Viriom’s 51 competitors is Agios Pharmaceuticals, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agios Pharmaceuticals Formerly VC-backed Cambridge, MA
Mustang Bio Formerly VC-backed Waltham, MA
MigVax Venture Capital-Backed Hazafon, Israel
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 51 competitors. Get the full list »

Viriom Patents

Viriom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026136285-A2 Method for preparation quisinostat base (n-hydroxy-2-(4-((((1-methyl-1h-indol-3-yl)methyl)amino)methyl)piperidin-1-yl) pyrimidine-5-carboxamide), quisinostat hydrochloride in polymorphic form a, and intermediate compounds for their synthesis Pending 17-Dec-2024
WO-2026136285-A3 Method for preparation quisinostat base (n-hydroxy-2-(4-((((1-methyl-1h-indol-3-yl)methyl)amino)methyl)piperidin-1-yl) pyrimidine-5-carboxamide), quisinostat hydrochloride in polymorphic form a, and intermediate compounds for their synthesis Pending 17-Dec-2024
WO-2024097908-A1 Combination therapy for covid19 disease: inhibiting pyrimidine biosynthesis Inactive 04-Nov-2022
US-20260345655-A1 Inhibiting purine biosynthesis to increase favipiravir potency against orthohantavirus infections Pending 16-May-2022
EP-4525915-A2 Inhibiting purine biosynthesis to increase favipiravir potency against rna virus infections Pending 16-May-2022 A61K31/4965
To view Viriom’s complete patent history, request access »

Viriom Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viriom FAQs

  • When was Viriom founded?

    Viriom was founded in 2009.

  • Where is Viriom headquartered?

    Viriom is headquartered in Rockville, MD.

  • What is the size of Viriom?

    Viriom has 4 total employees.

  • What industry is Viriom in?

    Viriom’s primary industry is Drug Discovery.

  • Is Viriom a private or public company?

    Viriom is a Private company.

  • What is Viriom’s current revenue?

    The current revenue for Viriom is .

  • How much funding has Viriom raised over time?

    Viriom has raised $17.4M.

  • Who are Viriom’s competitors?

    Agios Pharmaceuticals, Mustang Bio, MigVax, Sorrento Therapeutics, and Inovio Pharmaceuticals are some of the 51 competitors of Viriom.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process